Clinical involvement of the tonsillar immune system in IgA nephropathy

References

• Berger J, Hinglais N. Intercapillary deposits of IgA-IgG. J Urol Nephrol (Paris) 1968; 74: 694–5.
   PubMedGoogle Scholar
• Berger J, Noel LH, Nabarra B. Recurrence of mesangial IgA nephropathy after renal transplantation. Contrib Nephrol 1984; 40: 195–7.
   Google Scholar
• Berger J. Recurrence of IgA nephropathy in renal allografts. Am J Kidney Dis 1988; 12: 371–2.
   PubMed Web of Science ®Google Scholar
• Johansen FE, Braathen R, Brandtzaeg P Role of J chain in secretory immunoglobulin formation. Scand J Im-munol 2000; 52: 240–8.
   PubMed Web of Science ®Google Scholar
• D'Amico G. Idiopathic IgA mesangial nephropathy. Nephron 1985; 41: 1–13.
   PubMedGoogle Scholar
• Valentijn RM, Kauffmann RH, de la Riviere GB, Daha MR, Van ES LA. Presence of circulating macromole-cular IgA in patients with hematuria due to primary IgA nephropathy. Am J Med 1983; 74: 375–81.
   Google Scholar
• Harada T, Hobby P, Courteau M, Knight JF, Williams DG. Charge distribution of plasma IgA in IgA nephro-pathy. Clin Exp Immunol 1989; 77: 211–4.
   Google Scholar
• Tomino Y, Ohmuro H, Takahashi Y, Suzuki Y, Saka S, Tashiro K, Shirato I, Koide H. Binding capacity of serum IgA to jacalin in patients with IgA nephropathy using jacalin-coated microplates. Nephron 1995; 70: 329–33.
   PubMed Web of Science ®Google Scholar
• Mestecky J, Hashim OH, Tomana M. Alterations in the IgA carbohydrate chains influence the cellular distribu-tion of IgAl. Contrib Nephrol 1995; 111: 66–71.
   Google Scholar
• Hone A, Hiki Y, Odani H, Yasuda Y, Takahashi M, Kato M, Iwase H, Kobayashi Y, Nakashima I, Maeda K. IgAl molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy. Am J Kidney Dis 2003; 42: 486–96.
   PubMedGoogle Scholar
• Itoh A, Iwase H, Takatani T, Nakamura I, Hayashi M, Oba K, Hiki Y, Kobayashi Y, Okamoto M. Tonsillar IgAl as a possible source of hypoglycosylated IgAl in the serum of IgA nephropathy patients. Nephrol Dial Transplant 2003; 18: 1108–14.
   Google Scholar
• Linossier MT, Palle S, Berthoux F. Different glycosyla-tion profile of serum IgAl in IgA nephropathy accord-ing to the glomerular basement membrane thickness: normal versus thin. Am J Kidney Dis 2003; 41: 558–64.
   Google Scholar
• van den Wall Bake AW, Daha MR, Radl J, Haaijman JJ, Van der Ark A, Valentijn RM, Van Es LA. The bone marrow as production site of the IgA deposited in the kidneys of patients with IgA nephropathy. Clin Exp Immunol 1988; 72: 321–5.
   PubMedGoogle Scholar
• Harper SJ, Allen AC, Pringle JH, Feehally J. Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy determined by in situ hybridisation for J chain mRNA. J Clin Pathol 1996; 49: 38–42.
   PubMedGoogle Scholar
• Béné MC, Faure G, Hurault de Ligny B, Kessler M, Duheille J. Immunoglobulin A nephropathy. Quantita-tive immunohistomorphometry of the tonsillar plasma cells evidences an inversion of the immunoglobulin A versus immunoglobulin G secreting cell balance. J Clin Invest 1983; 71: 1342–7.
   Google Scholar
• Egido J, Blasco R, Lozano L, Sancho J, Garcia-Hoyo R. Immunological abnormalities in the tonsils of patients with IgA nephropathy: inversion in the ratio of IgA: IgG bearing lymphocytes and increased polymeric IgA synthesis. Clin Exp Immunol 1984; 57: 101–6.
   Google Scholar
• Garcia-Hoyo R, Egido J, Lozano L, de Nicolas R, Hernando L. Disturbances of IgA immune regulation in lymphocytes from mucosae and peripheral blood in patients with IgA nephropathy. Semin Nephrol 1987; 7: 301–5.
   Google Scholar
• Nagy J, Brandtzaeg P. Tonsillar distribution of IgA and IgG immunocytes and production of IgA subclasses and J chain in tonsillitis vary with the presence or absence of IgA nephropathy. Scand J Immunol 1988; 27: 393–9.
   PubMed Web of Science ®Google Scholar
• Béné MC, Hurault De Ligny B, Kessler M, Faure GC. Confirmation of tonsillar anomalies in IgA nephropa-thy: a multicenter study. Nephron 1991; 58: 425–8.
   Google Scholar
• Harper SJ, Allen AC, Bene MC, Pringle JH, Faure G, Lauder I, Feehally J. Increased dimeric IgA-producing B cells in tonsils in IgA nephropathy determined by in situ hybridization for J chain mRNA. Clin Exp Immunol 1995; 101: 442–8.
   Google Scholar
• Harper SJ, Pringle JH, Wicks AC, Hattersley J, Layward L, Allen A, Gillies A, Lauder I, Feehally J. Expression of J chain mRNA in duodenal IgA plasma cells in IgA nephropathy. Kidney Int 1994; 45: 836–44.
   Google Scholar
• Brandtzaeg P, Halstensen TS, Kett K, Krajci P, Kvale D, Rognum TO, Scott H, Sollid LM. Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes. Gastroenter-ology 1989; 97: 1562–84.
   PubMed Web of Science ®Google Scholar
• Béné MC, Faure G, Duheille J. IgA nephropathy: characterization of the polymeric nature of mesangial deposits by in vitro binding of free secretory component. Clin Exp Immunol 1982; 47: 527–34.
   Google Scholar
• Conley ME, Cooper MD, Michael AF. Selective deposi-tion of immunoglobulin Al in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest 1980; 66: 1432–6.
   Google Scholar
• Tomino Y, Endoh M, Nomoto Y, Sakai H. Immunoglo-bulin Al and IgA nephropathy. N Engl J Med 1981; 305: 1159–60.
   PubMedGoogle Scholar
• Clarkson AR, Woodroffe AJ, Aarons I, Hiki Y, Hale G. IgA nephropathy. Annu Rev Med 1987; 38: 157–68.
   PubMedGoogle Scholar
• Kennel-De March A, Béné MC, Hurault de Ligny B, Kessler M, Faure GC. Enhanced expression of CD31 and CD54 on tonsillar high endothelial venules in IgA nephropathy. Clin Immunol Immunopathol 1997; 84: 158–65.
   Google Scholar
• Kennel-De March A, Béné MC, Renoult E, Kessler M, Faure GC. Low levels of spontaneously activated peripheral IgA-secreting cells in nontransplanted IgA nephropathy patients. Am J Kidney Dis 1997; 30: 64–70.
   PubMedGoogle Scholar
• Kennel-de March A, Béné MC, Renoult E, Kessler M, Faure GC, Kolopp-Sarda MN. Enhanced expression of L-selectin on peripheral blood lymphocytes from pa-tients with IgA nephropathy. Clin Exp Immunol 1999; 115: 542–6.
   PubMedGoogle Scholar
• Tokuda M, Shimizu J, Sugiyama N, Kiryu T, Matsuoka K, Sasaki O, Fukuda K, Hatase O, Monden H. Direct evidence of the production of IgA by tonsillar lympho-cytes and the binding of IgA to the glomerular mesangium of IgA nephropathy patients. Acta Otolar-yngol 1996; Suppl. 523: 182–4.
   Google Scholar
• Kodama S, Suzuki M, Arita M, Mogi G. Increase in tonsillar germinal centre B-1 cell numbers in IgA nephropathy (IgAN) patients and reduced susceptibility to Fas-mediated apoptosis. Clin Exp Immunol 2001; 123: 301–8.
   PubMed Web of Science ®Google Scholar
• Suzuki S, Fujieda S, Sunaga H, Sugimoto H, Yamamoto C, Kimura H, Abo T, Gejyo F. Immune response of tonsillar lymphocytes to Haemophilus parainfluenzae in patients with IgA nephropathy. Clin Exp Immunol 2000; 119: 328–32.
   PubMed Web of Science ®Google Scholar
• Vialtel P, Dechelette E, Hachache T, Colomb H, Cordonnier D, Roux O, Dumas G, Accoyer B, Junien Lavillauraoy C, Charachon R. Role de l'amygdalectomie sur l'évolution des symptomes de la glomérulonéphrite &pots mésangiaux d'IgA. Semin Urol Néphrol 1981; 10: 173–85.
   Google Scholar
• Tamura S, Masuda Y, Inokuchi I, Terasawa K, Su-giyama N. Effect of and indication for tonsillectomy in IgA nephropathy. Acta Otolaryngol 1993; Suppl. 508: 23–8.
   Google Scholar
• Tomioka S, Miyoshi K, Tabata K, Hotta O, Taguma Y. Clinical study of chronic tonsillitis with IgA nephro-pathy treated by tonsillectomy. Acta Otolaryngol 1996; Suppl. 523: 175–7.
   Google Scholar
• Xie Y, Nishi S, Ueno M, Imai N, Sakatsume M, Narita I, Suzuki Y, Akazawa K, Shimada H, Arakawa M, Gejyo F. The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy. Kidney Int 2003; 63: 1861–7.
   Google Scholar
• Bene MC, Hurault de Ligny B, Kessler M, Foliguet B, Faure GC. Tonsils in IgA nephropathy. Contrib Nephrol 1993; 104: 153–61.
   PubMedGoogle Scholar